Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Solventum's enterprise value was $19.75B on Nov 11, 2026, against $18.28B a year earlier. Over the last 2 years it ranged from $15.49B to $21.03B, with a median of $19.45B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $19.75B | +14.6% |
| 2025 | Dec 31, 2025 | $17.24B | -8.1% |
| 2024 | Dec 31, 2024 | $18.75B | – |
See a number that looks wrong?